ArticleFrontiers in public health2025
Short-term trends in hypertension and high cardiovascular risk at high altitude in Peru.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim of the present study was to describe short-term trends in the prevalence of high cardiovascular risk and the prevalence, awareness, treatment, and controlled hypertension in the high altitude of Peru, during the years 2017 to 2023, using data from the Demographic and Family Health Survey. Methods: A cross-sectional analysis was carried out using secondary data of six representative surveys nationwide (2017-2023, excluding the 2020 survey). For the analysis of hypertension and cardiovascular risk, we included 56,404 and 38,221 participants residing in high-altitude areas, respectively. The mean and age-standardized prevalence were calculated with their respective 95% confidence intervals and the trends of the estimated proportions were evaluated with Mann-Kendall test. A value Results: An increase in the age-standardized prevalence of hypertension, disease knowledge, treatment, and controlled hypertension was identified between 2017 and 2023; however, no statistically significant trends were observed in these prevalences. The proportion of participants with high cardiovascular risk remained constant during this period. Conclusion: In participants residing in high-altitude cities in Peru, no statistically significant trends were found in the age-standardized prevalences of hypertension, disease knowledge, treatment, controlled hypertension, or cardiovascular risk between 2017 and 2023.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.